LY317615
Term · Oncology and biomedicine · MLC-T-ONC-005003
A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin hydrochloride.
| Identifier | MLC-T-ONC-005003 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | enzastaurin hydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005003",
"term": "LY317615",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin hydrochloride.",
"expansions": [
"enzastaurin hydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ly317615/"
}
Record 10,435 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.